Longevity Health Holdings, Inc.
XAGE
$0.52
-$0.02-3.39%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,977.56% | 3,994.31% | -- | -- | -99.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,977.56% | 3,994.31% | -- | -- | -99.45% |
| Cost of Revenue | 3,956.25% | 66,900.00% | -- | -- | -- |
| Gross Profit | 1,372.61% | 2,422.50% | -- | -- | -- |
| SG&A Expenses | 36.43% | 77.57% | 67.75% | -15.66% | 113.76% |
| Depreciation & Amortization | -9.44% | -5.53% | 2.13% | -22.03% | -22.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.32% | 96.23% | 46.13% | 207.63% | -32.13% |
| Operating Income | -5.25% | -55.99% | -9.16% | -202.37% | 33.09% |
| Income Before Tax | 50.33% | 42.91% | 57.62% | -11,266.29% | 68.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.33% | 42.91% | 57.62% | -10,173.03% | 68.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.33% | 42.91% | 53.96% | -128.96% | 74.89% |
| EBIT | -5.25% | -55.99% | -9.16% | -202.37% | 33.09% |
| EBITDA | -5.44% | -57.23% | -9.29% | -219.46% | 33.21% |
| EPS Basic | 79.92% | 67.39% | 64.52% | -132.51% | 77.72% |
| Normalized Basic EPS | 78.71% | 67.90% | 67.34% | -12,680.28% | 69.69% |
| EPS Diluted | 79.92% | 67.39% | 64.52% | -132.51% | 77.72% |
| Normalized Diluted EPS | 78.71% | 67.90% | 67.34% | -12,680.28% | 69.69% |
| Average Basic Shares Outstanding | 147.33% | 75.03% | 29.77% | -10.95% | 12.21% |
| Average Diluted Shares Outstanding | 147.33% | 75.03% | 29.77% | -10.95% | 12.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |